The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MYC protein expression as prognostic in acute myeloid leukemia.
 
Maro Ohanian
No Relationships to Disclose
 
Uri Rozovski
No Relationships to Disclose
 
Hagop M Kantarjian
No Relationships to Disclose
 
Sanam Loghavi
No Relationships to Disclose
 
Lynne Abruzzo
No Relationships to Disclose
 
Zhuang Zuo
No Relationships to Disclose
 
Yang Huh
No Relationships to Disclose
 
Guillermo Garcia-Manero
No Relationships to Disclose
 
Farhad Ravandi
Honoraria - Amgen; Pfizer; Seagen; Sunesis Pharmaceuticals
Consulting or Advisory Role - Amgen; Seagen; Sunesis Pharmaceuticals
Research Funding - Amgen; Bristol-Myers Squibb; Merck; Seagen; Sunesis Pharmaceuticals
 
Michael Andreeff
No Relationships to Disclose
 
Steven Mitchell Kornblau
No Relationships to Disclose
 
Gautam Borthakur
No Relationships to Disclose
 
Martin H. Nguyen
No Relationships to Disclose
 
Peter Hu
No Relationships to Disclose
 
L Jeffrey Medeiros
No Relationships to Disclose
 
Graciela M. Nogueras-Gonzalez
No Relationships to Disclose
 
Xuelin Huang
No Relationships to Disclose
 
Zeev Estrov
No Relationships to Disclose
 
Carlos E. Bueso-Ramos
No Relationships to Disclose
 
Jorge E. Cortes
Consulting or Advisory Role - Ambit BioSciences; Amphivena Therapeutics; ARIAD; Astellas Pharma; BiolineRx; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Ambit BioSciences (Inst); ARIAD (Inst); Arog (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst); Teva (Inst)